Market by Gender, End-user, and Geography | Forecast 2021-2028
After a detailed analysis, Triton Market Research’s report has determined that the global infertility testing and treatment market is expected to display an upward trend in terms of revenue. In addition, it is estimated to grow at a CAGR of 10.15% during the forecasting years 2021-2028. The market accounted for $13.43 billion in 2020 and is expected to reach $32.94 billion by 2028.
Report scope can be customized per your requirements. Request For Customization
Globally, infertility is growing due to poor
nutrition, stress, delayed marriages, increased work hours, changing
lifestyles, and environmental pollution, among others. Thus, more people are
visiting fertility clinics and medical institutes to seek treatments for
infertility due to these factors. This has augmented the growth of the
infertility testing and treatment market.
Triton’s report on the infertility testing and
treatment market report gives a detailed analysis of the key insight, Porter’s
five forces analysis, key buying impact analysis, market attractiveness index,
industry components, vendor scorecard, and impact of COVID-19 on the market.
The rise in stress and lifestyle disorders,
rising trends in delayed marriages and pregnancies, enhancement in treatments,
and supportive governmental measures are driving the growth of the studied
market. Stress and Obesity have a detrimental impact on fertility. Furthermore,
the delay in marriages owing to work commitments, coupled with late
pregnancies, is another set of factors supporting the market’s growth. As per
various studies, fertility begins to decline after a certain age, lowering the
fertility of an individual.
Factors such as technological advancements in
time-lapse technology may generate new opportunities for the studied market.
Time-lapse technology permits scientists to understand the development of
embryos and helps them monitor the development of IVF embryos before
transferring them into the womb. Further, this technology’s use gives a precise
understanding of the embryos indicating the risk of having chromosomal
abnormalities.
However, the high cost, social taboo pertaining to infertility, and risk associated with treatments are hampering the market’s growth. Infertility treatment costs are quite high, which restricts the majority of people to seek this treatment. Moreover, the lack of a 100% guarantee of the treatment’s success challenges the overall growth of the infertility testing and treatment market.
Major geographies covered in the infertility
testing and treatment market are:
•          North America: United States and Canada
•          Europe:
United Kingdom, Germany, France, Italy, Spain, Russia, and Rest of Europe
•          Asia-Pacific:
China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand,
and Rest of Asia-Pacific
•          Latin America: Brazil, Mexico, and Rest of Latin America
•          Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and
Rest of Middle East & Africa
The infertility testing and treatment market, in
this report, is segmented as:
•          Based on Gender:
          o         Male
                     •         Male Infertility Testing
                                o        DNA Fragmentation
                                o        Oxidative Stress Analysis
                                o        Sperm Penetration Assay
                                o        Computer-Assisted Semen Analysis (CASA)
                                o        Sperm Agglutination
                                o        Microscopic Examination
                                o        Others
                     •         Male Infertility Treatment
                                o        Medication
                                o        Assisted Reproductive Technology & Varicocele Surgery
          o         Female
                     •         Female Infertility Testing
                               o         Ovulation Testing
                               o         Hysterosalpingography
                               o         Laparoscopy
                               o         Transvaginal Ultrasound
                               o         Ovarian Reserve Testing
                               o         Hormonal Level Testing
                               o         Others
                     •         Female Infertility Treatment
                               o         IVF with ICSI
                               o         IUI
                               o         IVF without ICSI
                               o         Surrogacy
                               o         Others
•          Based on End-user:
          o         Fertility
and Surgical Centers
          o         Hospitals
and Research Laboratories
          o         Cryobanks
The
major companies in the infertility testing and treatment market are Create
Fertility Centre, Genea Ltd, Fujifilm Irvine Scientific, EMD Group (Merck
KGAA), Bangkok IVF Center, Vitrolife AB, Progyny, Ferring Pharmaceuticals,
Adorfem, Endo International Plc, Cooper Surgical, Olympus Corporation, Cook
Medical Inc, Labotect GmbH, and Halotech DNA.  Â
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. KEY
INSIGHTS
2.1.1. GROWING
DEMAND FOR LOW-COST PROCEDURES
2.1.2. INCREASING
ACCEPTANCE OF DONOR EGGS
2.1.3. USE OF
AI INCREASES THE SUCCESS OF IVF TREATMENTS
2.2. IMPACT
OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. TREATMENT
OPTIONS
2.4.2. QUALITY
OF MEDICAL PROCEDURES
2.4.3. PRICE
OF TREATMENTS
2.4.4. SHIFT
TOWARDS MEDICAL TOURISM
2.4.5. REIMBURSEMENT
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. INDUSTRY
COMPONENTS
2.6.1. RAW
MATERIAL PROCUREMENT
2.6.2. MANUFACTURING
2.6.3. SUPPLY
LOGISTICS
2.6.4. DISTRIBUTION
CHANNELS
2.6.5. END-USERS
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
& PARTNERSHIPS
2.8.2. ACQUISITIONS
& MERGERS
2.8.3. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. GROWTH
IN STRESS AND LIFESTYLE DISORDERS
2.9.2. RISING
TREND IN DELAYED MARRIAGES AND PREGNANCIES
2.9.3. IMPROVEMENTS
IN TREATMENTS
2.9.4. GOVERNMENT
SUPPORT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST
2.10.2. SOCIAL
TABOO PERTAINING TO INFERTILITY
2.10.3. RISKS
ASSOCIATED WITH TREATMENTS
2.11. MARKET
OPPORTUNITIES
2.11.1. TECHNOLOGY
ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY
2.11.2. ADVANCES
IN EMBRYO BIOPSY AND GENETIC SCREENING
3. GLOBAL
INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER
3.1. MALE
3.1.1. MALE
INFERTILITY TESTING
3.1.1.1. DNA
FRAGMENTATION
3.1.1.2. OXIDATIVE
STRESS ANALYSIS
3.1.1.3. SPERM
PENETRATION ASSAY
3.1.1.4. COMPUTER-ASSISTED
SEMEN ANALYSIS (CASA)
3.1.1.5. SPERM
AGGLUTINATION
3.1.1.6. MICROSCOPIC
EXAMINATION
3.1.1.7. OTHERS
3.1.2.  MALE
INFERTILITY TREATMENT
3.1.2.1. MEDICATION
3.1.2.2. ASSISTED
REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
3.2. FEMALE
3.2.1. FEMALE
INFERTILITY TESTING
3.2.1.1. OVULATION
TESTING
3.2.1.2. HYSTEROSALPINGOGRAPHY
3.2.1.3. LAPAROSCOPY
3.2.1.4. TRANSVAGINAL
ULTRASOUND
3.2.1.5. OVARIAN
RESERVE TESTING
3.2.1.6. HORMONAL
LEVEL TESTING
3.2.1.7. OTHERS
3.2.2. FEMALE
INFERTILITY TREATMENT
3.2.2.1. IVF
WITH ICSI
3.2.2.2. IUI
3.2.2.3. IVF
WITHOUT ICSI
3.2.2.4. SURROGACY
3.2.2.5. THERS
4. GLOBAL
INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER
4.1. FERTILITY
AND SURGICAL CENTERS
4.2. HOSPITALS
& RESEARCH LABORATORIES
4.3. CRYOBANKS
5. GLOBAL
INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1. MARKET
BY GENDER
5.1.1.1. MARKET
BY MALE
5.1.1.1.1. MARKET
BY MALE INFERTILITY TESTING
5.1.1.1.2. MARKET
BY MALE INFERTILITY TREATMENT
5.1.1.2. MARKET
BY FEMALE
5.1.1.2.1. MARKET
BY FEMALE INFERTILITY TESTING
5.1.1.2.2. MARKET
BY FEMALE INFERTILITY TREATMENT
5.1.2. MARKET
BY END-USER
5.1.3. COUNTRY
ANALYSIS
5.1.3.1. UNITED
STATES
5.1.3.2. CANADA
5.2. EUROPE
5.2.1. MARKET
BY GENDER
5.2.1.1. MARKET
BY MALE
5.2.1.1.1. MARKET
BY MALE INFERTILITY TESTING
5.2.1.1.2. MARKET
BY MALE INFERTILITY TREATMENT
5.2.1.2. MARKET
BY FEMALE
5.2.1.2.1. MARKET
BY FEMALE INFERTILITY TESTING
5.2.1.2.2. MARKET
BY FEMALE INFERTILITY TREATMENT
5.2.2. MARKET
BY END-USER
5.2.3. COUNTRY
ANALYSIS
5.2.3.1. UNITED
KINGDOM
5.2.3.2. GERMANY
5.2.3.3. FRANCE
5.2.3.4. SPAIN
5.2.3.5. ITALY
5.2.3.6. RUSSIA
5.2.3.7. REST
OF EUROPE
5.3. ASIA-PACIFIC
5.3.1. MARKET
BY GENDER
5.3.1.1. MARKET
BY MALE
5.3.1.1.1. MARKET
BY MALE INFERTILITY TESTING
5.3.1.1.2. MARKET
BY MALE INFERTILITY TREATMENT
5.3.1.2. MARKET
BY FEMALE
5.3.1.2.1. MARKET
BY FEMALE INFERTILITY TESTING
5.3.1.2.2. MARKET
BY FEMALE INFERTILITY TREATMENT
5.3.2. MARKET
BY END-USER
5.3.3. COUNTRY
ANALYSIS
5.3.3.1. CHINA
5.3.3.2. JAPAN
5.3.3.3. INDIA
5.3.3.4. SOUTH
KOREA
5.3.3.5. ASEAN
COUNTRIES
5.3.3.6. AUSTRALIA
& NEW ZEALAND
5.3.3.7. REST
OF ASIA-PACIFIC
5.4. LATIN
AMERICA
5.4.1. MARKET
BY GENDER
5.4.1.1. MARKET
BY MALE
5.4.1.1.1. MARKET
BY MALE INFERTILITY TESTING
5.4.1.1.2. MARKET
BY MALE INFERTILITY TREATMENT
5.4.1.2. MARKET
BY FEMALE
5.4.1.2.1. MARKET
BY FEMALE INFERTILITY TESTING
5.4.1.2.2. MARKET
BY FEMALE INFERTILITY TREATMENT
5.4.2. MARKET
BY END-USER
5.4.3. COUNTRY
ANALYSIS
5.4.3.1. BRAZIL
5.4.3.2. MEXICO
5.4.3.3. REST
OF LATIN AMERICA
5.5. MIDDLE
EAST AND AFRICA
5.5.1. MARKET
BY GENDER
5.5.1.1. MARKET
BY MALE
5.5.1.1.1. MARKET
BY MALE INFERTILITY TESTING
5.5.1.1.2. MARKET
BY MALE INFERTILITY TREATMENT
5.5.1.2. MARKET
BY FEMALE
5.5.1.2.1. MARKET
BY FEMALE INFERTILITY TESTING
5.5.1.2.2. MARKET
BY FEMALE INFERTILITY TREATMENT
5.5.2. MARKET
BY END-USER
5.5.3. COUNTRY
ANALYSIS
5.5.3.1. UNITED
ARAB EMIRATES
5.5.3.2. TURKEY
5.5.3.3. SAUDI
ARABIA
5.5.3.4. SOUTH
AFRICA
5.5.3.5. REST
OF MIDDLE EAST & AFRICA
6. COMPETITIVE
LANDSCAPE
6.1. ADORFEM
6.2. BANGKOK
IVF CENTER
6.3. COOK
MEDICAL INC
6.4. COOPER
SURGICAL
6.5. CREATE
FERTILITY CENTRE
6.6. EMD
GROUP (MERCK KGAA)
6.7. ENDO
INTERNATIONAL PLC
6.8. FERRING
PHARMACEUTICALS
6.9. HALOTECH
DNA
6.10. GENEA
LTD
6.11. FUJIFILM
IRVINE SCIENTIFIC
6.12. VITROLIFE
AB
6.13. LABOTECT
GMBH
6.14. OLYMPUS
CORPORATION
6.15. PROGYNY
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS
MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS
& PARTNERSHIPS
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES
TABLE 7: AVERAGE COST
COMPARISON OF INFERTILITY TREATMENTS
TABLE 8: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
TABLE 11: PROS AND CONS OF DNA
SHARING METHODS
TABLE 12: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
TABLE 13: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
TABLE 15: COST OF OVULATION
TESTING KITS IN THE US
TABLE 16: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
TABLE 17: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028, (IN $ MILLION)
TABLE 18: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
TABLE 20: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028
(IN $ MILLION)
TABLE 23: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
TABLE 24: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
TABLE 25: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 26: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
TABLE 27: NORTH AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 28: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 29: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 30: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
TABLE 31: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
TABLE 32: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
TABLE 33: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
TABLE 34: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
TABLE 35: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
TABLE 36: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
TABLE 38: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 39: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
TABLE 40: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 41: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
TABLE 42: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
TABLE 43: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 44: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
TABLE 45: ASIA-PACIFIC
INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 46: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
TABLE 47: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 48: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
TABLE 49: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 50: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028
(IN $ MILLION)
TABLE 51: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
TABLE 52: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 53: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
TABLE 54: LATIN AMERICA
INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 55: MIDDLE EAST AND AFRICA
INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
TABLE 56: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $
MILLION)
TABLE 57: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $
MILLION)
TABLE 58: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 59: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
TABLE 60: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $
MILLION)
TABLE 61: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 62: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY
TREATMENT, 2021-2028 (IN $ MILLION)
TABLE 63: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $
MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)
FIGURE 5: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028
FIGURE 7: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
FIGURE 8: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN
%)
FIGURE 9: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)
FIGURE 10: CAUSES OF SPERM DNA
FRAGMENTATION
FIGURE 11: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $
MILLION)
FIGURE 12: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $
MILLION)
FIGURE 13: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA),
2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $
MILLION)
FIGURE 16: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
FIGURE 18: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028
(IN %)
FIGURE 19: GLOBAL INFERTILITY TESTING
AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY &
VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %)
FIGURE 23: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
FIGURE 24: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028
FIGURE 25: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)
FIGURE 26: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $
MILLION)
FIGURE 27: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 28: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $
MILLION)
FIGURE 29: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $
MILLION)
FIGURE 30: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $
MILLION)
FIGURE 31: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 32: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
FIGURE 33: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028
(IN %)
FIGURE 34: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)
FIGURE 35: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)
FIGURE 36: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)
FIGURE 37: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)
FIGURE 38: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 39: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 40: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN
$ MILLION)
FIGURE 41: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES,
2021-2028 (IN $ MILLION)
FIGURE 42: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)
FIGURE 43: GLOBAL INFERTILITY
TESTING AND TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 44: UNITED STATES
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: CANADA INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: UNITED KINGDOM
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: GERMANY INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 48: FRANCE INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 49: SPAIN INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 50: ITALY INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 51: RUSSIA INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 52: REST OF EUROPE
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 53: CHINA INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 54: JAPAN INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 55: INDIA INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 56: SOUTH KOREA
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 57: ASEAN COUNTRIES
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 58: AUSTRALIA & NEW
ZEALAND INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 59: REST OF
ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 60: BRAZIL INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 61: MEXICO INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 62: REST OF LATIN
AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 63: UNITED ARAB
EMIRATES INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 64: TURKEY INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 65: SAUDI ARABIA
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 66: SOUTH AFRICA
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 67: REST OF MIDDLE EAST
& AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)